Please check your internet connection and try again.
## HepaMerz (L-Ornithine L-Aspartate)
### Overview
HepaMerz is a combination of the amino acids L-ornithine and L-aspartate. It is primarily used in the management of hyperammonemia associated with liver dysfunction.
### Primary Indications
* Treatment of latent and manifest hepatic encephalopathy (HE), particularly in patients with cirrhosis.
### Adult Dosing
* **Hepatic Encephalopathy:** The typical dose is 3 sachets (each containing 6g L-ornithine L-aspartate) per day, divided into 2-3 doses.
* **Maximum Dose:** Generally, do not exceed 6 sachets (18g) per day. Specific maximums may vary based on severity and individual tolerance.
### Pediatric Dosing
* There is **limited established pediatric dosing** for HepaMerz. Use in pediatric patients should be based on expert clinical judgment and potentially extrapolated from adult data, with caution.
### Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are typically outlined, but caution is advised as clearance may be reduced.
* **Hepatic Impairment:** This drug is intended for patients with liver dysfunction; dose adjustments are generally not required for the liver condition itself, but monitoring is crucial.
### Contraindications
* Severe renal failure (creatinine clearance < 25 mL/min).
* Hypersensitivity to L-ornithine L-aspartate or any component of the formulation.
### Adverse Effects
* **Common:** Nausea, vomiting, abdominal pain, diarrhea, flatulence.
* **Less Common:** Dizziness, headache, fatigue, skin rash, itching.
* **Rare:** Allergic reactions.
### Key Drug Interactions
* No significant drug interactions are well-documented. However, monitor patients closely for any additive effects if co-administered with other medications affecting ammonia levels or gastrointestinal motility.
### Monitoring
* **Ammonia Levels:** Periodic monitoring of serum ammonia levels is recommended to assess efficacy.
* **Renal Function:** Monitor renal function, especially in patients with pre-existing renal impairment.
* **Hepatic Function:** Continue to monitor liver function tests.
* **Clinical Signs of HE:** Assess for improvement in neurological symptoms.
### Clinical Pearls
* HepaMerz aids in the detoxification of ammonia in the liver and peripheral tissues by promoting its conversion to urea (in the liver) and glutamine (in muscles and other tissues).
* Oral administration should be taken with or after meals.
* The sachets can be dissolved in a suitable liquid (e.g., water, juice).
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and local institutional protocols before initiating or modifying drug therapy.*
